NASDAQ:LYEL

Lyell Immunopharma Stock Insider Trading

etoro logo Buy LYEL
*Your capital is at risk
$12.57
-2.32 (-15.58%)
At Close: Jun 03, 2026

Lyell Immunopharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 93.60. In total, the insiders bought 4.74M and sold 39.63K LYEL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
93.60
Buy 4.74M shares
Sell 39.63K shares
63% Buy Activity
Moderate Negative Correlation
Buy Signal Medium Confidence
Mar 06, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 93.6.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 10, 2025
Sell
Common Stock
S-Sale
Seely Lynn
President And CEO
CEO / President 412
Value: $7K
Oct 31, 2025
Buy
Option (right to buy)
Bulis Veronica Sanchez
Vp, Corporate Controller
Officer 3 000
Value: $112.2K
Oct 31, 2025
Buy
Option (right to buy)
Bulis Veronica Sanchez
Vp, Corporate Controller
Officer 1 674
Value: $71.3K
Oct 31, 2025
Buy
Common Stock
Bulis Veronica Sanchez
Vp, Corporate Controller
Officer 0
Value: $0
Oct 27, 2025
Buy
Option (right to buy)
A-Award
Seely Lynn
President And CEO
CEO / President 175 000
Value: $3.02M
Oct 27, 2025
Buy
Option (right to buy)
A-Award
Lee Gary K.
Chief Scientific Officer
Officer 68 000
Value: $1.17M
Oct 27, 2025
Buy
Option (right to buy)
A-Award
Hill Stephen J.
Chief Operating Officer
C-Suite Officer 75 000
Value: $1.29M
Aug 21, 2025
Sell
Common Stock
S-Sale
Seely Lynn
President And CEO
CEO / President 7 257
Value: $76.5K
Aug 21, 2025
Sell
Common Stock
S-Sale
Hill Stephen J.
Chief Operating Officer
C-Suite Officer 1 004
Value: $10.6K
Aug 21, 2025
Sell
Common Stock
S-Sale
Newton Charles W.
Chief Financial Officer
C-Suite Officer 1 453
Value: $15.3K
Aug 21, 2025
Sell
Common Stock
S-Sale
Lee Gary K.
Chief Scientific Officer
Officer 1 453
Value: $15.3K
Aug 21, 2025
Sell
Common Stock
S-Sale
Lee Gary K.
Chief Scientific Officer
Officer 1 453
Value: $15.3K
Aug 21, 2025
Sell
Common Stock
S-Sale
Newton Charles W.
Chief Financial Officer
C-Suite Officer 1 453
Value: $15.3K
Aug 21, 2025
Sell
Common Stock
S-Sale
Hill Stephen J.
Chief Operating Officer
C-Suite Officer 1 004
Value: $10.6K
Aug 21, 2025
Sell
Common Stock
S-Sale
Seely Lynn
President And CEO
CEO / President 7 257
Value: $76.5K
Aug 20, 2025
Buy
Common Stock
A-Award
Seely Lynn
President And CEO
CEO / President 40 000
Value: $426.0K
Aug 20, 2025
Buy
Common Stock
A-Award
Hill Stephen J.
Chief Operating Officer
C-Suite Officer 8 000
Value: $85.2K
Aug 20, 2025
Buy
Common Stock
A-Award
Newton Charles W.
Chief Financial Officer
C-Suite Officer 8 000
Value: $85.2K
Aug 20, 2025
Buy
Common Stock
A-Award
Lee Gary K.
Chief Scientific Officer
Officer 8 000
Value: $85.2K
Aug 20, 2025
Buy
Common Stock
A-Award
Lee Gary K.
Chief Scientific Officer
Officer 8 000
Value: $85.2K
Aug 20, 2025
Buy
Common Stock
A-Award
Newton Charles W.
Chief Financial Officer
C-Suite Officer 8 000
Value: $85.2K
Aug 20, 2025
Buy
Common Stock
A-Award
Hill Stephen J.
Chief Operating Officer
C-Suite Officer 8 000
Value: $85.2K
Aug 20, 2025
Buy
Common Stock
A-Award
Seely Lynn
President And CEO
CEO / President 40 000
Value: $426.0K
Aug 12, 2025
Sell
Common Stock
S-Sale
Seely Lynn
President And CEO
CEO / President 406
Value: $4K
Aug 12, 2025
Sell
Common Stock
S-Sale
Hill Stephen J.
Chief Operating Officer
C-Suite Officer 94
Value: $972

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT LYELL IMMUNOPHARMA, INC.
Lyell Immunopharma
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE